The UMD-FBN1 mutations database
Record ID: 2843

Mutation description


Variation name (cDNA level)Variation name (protein level)Variation statusVariation class
c.1868G>Tp.Cys623PheHeterozygousMutation

wt codonwt aamutant codonmutant aamutational eventmutation type
TGCCysTTCPheG->TTv

StructureKey Residue (HCD)Pyrimidin doubletCpG
cb EGF-like #06 Disulfide bonds 623-637 (C2)NoNo

Mutation impact


At the mRNA levelOn restriction map
NANew restriction site(s): BspH I
Lost restriction site(s): none

Conservation (0-1)SIFT (0-1)UMD-predictor (0-100)
0.830.00 (pathogenous)100 (Pathogenous)

Patient and sample data


Sample IDPatient statusGenderTransmissionAge of onsetAge of deathGeographic origin
USA09FAR F0004 I01ProbandMalede novoU.S.A.

Phenotypic groupDisease
NAMFS

Clinical data


SymptomSeverityAge
33
C-Asc. aortic dilatation33
CNS-Lumbosacral dural ectasia33
O-Ectopia lentisbilateral33
S-High arched palate33
S-Pectus excavatum moderate (m)(1)33
S-Reduced US/LS ratio <0.87 (M)33
SI-Significant striae atrophicae (m)(1)shoulder33
SI-Significant striae atrophicae (m)(1)flank33
SI-Significant striae atrophicae (m)(1)hip33

Reference


Reference IDPubMed IDReference
21011251996
Toudjarska I, Kilpatrick MW, Lembessis P, Carra S, Harton GL, Sisson ME, Black SH, Stern HJ, Gelman-Kohan Z, Shohat M, Tsipouras P. "Novel approach to the molecular diagnosis of Marfan syndrome: application to sporadic cases and in prenatal diagnosis". Am J Med Genet. 2001 Apr 1;99(4):294-302.